PRP in Ophthalmology

PRP in ophthalmology is a relatively new phenomena, with recent research shedding on how PRP can help with various eye conditions, focusing on improving eyesight and advancing treatment options. Below summarises three research studies into various ophthalmological conditions, and T-Lab PRP in application on these. 

Deep Retinal Capillary Ischemia

In a 2019 study, researchers explored the effects of combining retinal electromagnetic stimulation with T-Lab’s PRP for treating deep retinal capillary ischemia. Participants were divided into three groups: one received only electromagnetic stimulation, another received both treatments, and the third served as a control group. While the group receiving electromagnetic stimulation alone showed some improvement, the combination of PRP and electromagnetic stimulation achieved the best results.

Importantly, this combined treatment was the only one to significantly improve best corrected visual acuity. Thus, PRP used alongside electromagnetic stimulation proves to be highly effective for severe deep retinal capillary ischemia, greatly enhancing overall eyesight recovery.

Retinitis Pigmentosa

Similarly, a 2020 study investigated whether subtenon PRP, with or without retinal electromagnetic stimulation, could slow the progression of retinitis pigmentosa, a degenerative eye disease. Both treatments led to clear improvements in the ellipsoid zone width and visual field. Furthermore, these gains remained steady for a year. Therefore, PRP combined with electromagnetic stimulation effectively manages retinitis pigmentosa and can enhance long-term eyesight.

Chronic Central Serous Chorioretinopathy

Moreover, another study examined whether subtenon PRP combined with retinal electromagnetic stimulation is effective for chronic central serous chorioretinopathy, particularly in cases resistant to other treatments. The group receiving both PRP and stimulation showed the most significant improvement in best-corrected visual acuity and submacular thickness, with a 51% gain. Compared to traditional treatments like micropulse laser or photodynamic therapy, PRP combined with electromagnetic stimulation proved to be a superior and safer option. As a result, this combination leads to improved eyesight even in difficult cases.

References

Özmert E, Arslan U. Management of Deep Retinal Capillary Ischemia by Electromagnetic Stimulation and Platelet-Rich Plasma: Preliminary Clinical Results. Adv Ther. 2019 Sep;36(9):2273-2286. doi: 10.1007/s12325-019-01040-2. Epub 2019 Aug 5. PMID: 31385285.

Arslan U, Özmert E. Management of Retinitis Pigmentosa via Platelet-Rich Plasma or Combination with Electromagnetic Stimulation: Retrospective Analysis of 1-Year Results. Adv Ther. 2020 May;37(5):2390-2412. doi: 10.1007/s12325-020-01308-y. Epub 2020 Apr 18. PMID: 32303913.

Arslan, U., & Özmert, E. (2020). Treatment of Resistant Chronic Central Serous Chorioretinopathy via Platelet-Rich Plasma with Electromagnetic Stimulation. Regenerative Medicine, 15(8), 2001–2014. https://doi.org/10.2217/rme-2020-0056

Contact form